Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) fell 9.5% during mid-day trading on Thursday . The company traded as low as C$0.10 and last traded at C$0.10. 167,544 shares were traded during trading, an increase of 63% from the average session volume of 102,479 shares. The stock had previously closed at C$0.11.
Voyageur Pharmaceuticals Price Performance
The company’s 50 day simple moving average is C$0.07 and its 200 day simple moving average is C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market cap of C$13.25 million, a P/E ratio of -9.50 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Bank Stocks – Best Bank Stocks to Invest In
- Micron Stock Under $100: Seize the AI-Driven Upside
- What Does Downgrade Mean in Investing?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- High Dividend REITs: Are They an Ideal Way to Diversify?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
